10x Genomics, Inc.
TXG
$27.25
-$0.23-0.84%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -255.10M | -223.36M | -172.29M | -174.33M | -166.00M |
| Total Depreciation and Amortization | 43.62M | 40.39M | 37.08M | 33.65M | 33.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 178.94M | 174.81M | 168.90M | 156.54M | 138.81M |
| Change in Net Operating Assets | 17.34M | -19.07M | -45.18M | -32.78M | -39.42M |
| Cash from Operations | -15.20M | -27.23M | -11.49M | -16.93M | -33.61M |
| Capital Expenditure | -48.60M | -84.89M | -106.22M | -108.08M | -131.66M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -2.50M | -4.00M | -4.00M | -4.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 182.09M | 174.61M | 159.91M | 138.71M | -215.23M |
| Cash from Investing | 133.49M | 87.22M | 49.69M | 26.63M | -350.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.81M | -5.81M | -5.81M | -5.81M | -5.41M |
| Issuance of Common Stock | 19.48M | 18.87M | 16.54M | 15.80M | 21.23M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.67M | 13.06M | 10.72M | 9.99M | 15.82M |
| Foreign Exchange rate Adjustments | -33.00K | 141.00K | 141.00K | -2.00K | -44.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 131.93M | 73.19M | 49.06M | 19.68M | -368.72M |
